testosterone replacement therapy
Lipocine signs supply and distribution agreement with Pharmalink for Tlando
Lipocine announced an exclusive supply and distribution agreement with Pharmalink to commercialize Tlando, its oral testosterone replacement therapy, in the Gulf Cooperation Council countries consisting of Saudi Arabia, Kuwait,...